|
New York, NY, November 18, 2009-Ebitda News reports that negative EBITDA for SCOLR Pharma, Inc. (AMEX:DDD) for its quarter ended September 30, 2009 was $(1,503,197), a 50% improvement over the year ea ... read full story |
|
| Website Address: |
www.scolr.com |
| Industry: |
Vitamins & Nutraceuticals
|
|